Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11103)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 26, 2020 (publication date) through Nov 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ji HL, Liu C, Zhao RZ. Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials. World J Stem Cells 2020; 12(6): 471-480 [PMID: 32742564 DOI: 10.4252/wjsc.v12.i6.471] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v12/i6/471.htm |
| Number | Citing Articles |
| 1 |
Lin Yin, Na Li, Weihua Jia, Nuoqi Wang, Meidai Liang, Xiuying Yang, Guanhua Du. Skeletal muscle atrophy: From mechanisms to treatments. Pharmacological Research 2021; 172: 105807 doi: 10.1016/j.phrs.2021.105807
|
| 2 |
Ji-Hong Xu, Jia-Ping Liang, Chu-Jun Zhu, Yu-Jun Lian, Yuli Huang. Mesenchymal Stem Cell-Derived Extracellular Vesicles Therapy for Pulmonary Hypertension: A Comprehensive Review of Preclinical Studies. Journal of Interventional Cardiology 2022; 2022: 1 doi: 10.1155/2022/5451947
|
| 3 |
Kristen D. Popowski, Adele Moatti, Grant Scull, Dylan Silkstone, Halle Lutz, Blanca López de Juan Abad, Arianna George, Elizabeth Belcher, Dashuai Zhu, Xuan Mei, Xiao Cheng, Megan Cislo, Asma Ghodsi, Yuheng Cai, Ke Huang, Junlang Li, Ashley C. Brown, Alon Greenbaum, Phuong-Uyen C. Dinh, Ke Cheng. Inhalable dry powder mRNA vaccines based on extracellular vesicles. Matter 2022; 5(9): 2960 doi: 10.1016/j.matt.2022.06.012
|
| 4 |
Anna Ulldemolins, Alicia Jurado, Carolina Herranz-Diez, Núria Gavara, Jorge Otero, Ramon Farré, Isaac Almendros. Lung Extracellular Matrix Hydrogels-Derived Vesicles Contribute to Epithelial Lung Repair. Polymers 2022; 14(22): 4907 doi: 10.3390/polym14224907
|
| 5 |
Gonzalo Rescala, Ramiro Ramos-de la Cruz, Mónica Robles. Diez años de investigación en vesículas extracelulares de células mesenquimales para tratar enfermedades pulmonares. NCT Neumología y Cirugía de Tórax 2021; 80(3): 179 doi: 10.35366/102478
|
| 6 |
Eleonore Fröhlich. Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases—Intravenous Administration versus Inhalation. Pharmaceutics 2021; 13(2): 232 doi: 10.3390/pharmaceutics13020232
|
| 7 |
Shengnan Yang, Peipei Liu, Tingting Gao, Dingyun Song, Xinyu Zhao, Yupeng Li, Jun Wu, Liu Wang, Zai Wang, Jie Hao, Chen Wang, Huaping Dai. Every road leads to Rome: therapeutic effect and mechanism of the extracellular vesicles of human embryonic stem cell-derived immune and matrix regulatory cells administered to mouse models of pulmonary fibrosis through different routes. Stem Cell Research & Therapy 2022; 13(1) doi: 10.1186/s13287-022-02839-7
|
| 8 |
Chukwuebuka Emmanuel Umeyor, Popat Kumbhar, Tochukwu Okeke, Abdul-Azeez Anjorin, Abhit Nayak, Emmanuella Ezewudo, Vandana B. Patravale. Technological Advances and Innovations in the Treatment of Chronic Respiratory Disorders. 2025; : 99 doi: 10.1016/B978-0-443-27345-2.00004-7
|
| 9 |
Yuqian Feng, Kaibo Guo, Jing Jiang, Shengyou Lin. Mesenchymal stem cell-derived exosomes as delivery vehicles for non-coding RNAs in lung diseases. Biomedicine & Pharmacotherapy 2024; 170: 116008 doi: 10.1016/j.biopha.2023.116008
|
| 10 |
Eugenia D. Namiot, Diana Smirnovová, Aleksandr V. Sokolov, Vladimir N. Chubarev, Vadim V. Tarasov, Helgi B. Schiöth. The international clinical trials registry platform (ICTRP): data integrity and the trends in clinical trials, diseases, and drugs. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1228148
|
| 11 |
Xinkang Zhang, Jiehui Cai, Lingzhi Chen, Qiuping Yang, Huiting Tian, Jinyao Wu, Zeqi Ji, Daitian Zheng, Zhiyang Li, Yexi Chen. Mapping global trends in research of stem cell therapy for COVID-19: A bibliometric analysis. Frontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.1016237
|
| 12 |
Bei-Cyuan Guo, Kang-Hsi Wu, Chun-Yu Chen, Wen-Ya Lin, Yu-Jun Chang, Tai-An Lee, Mao-Jen Lin, Han-Ping Wu. Mesenchymal Stem Cells in the Treatment of COVID-19. International Journal of Molecular Sciences 2023; 24(19): 14800 doi: 10.3390/ijms241914800
|
| 13 |
Ahmed E. Altyar, Amr El-Sayed, Ahmed Abdeen, Marina Piscopo, Shaker A. Mousa, Agnieszka Najda, Mohamed M. Abdel-Daim. Future regenerative medicine developments and their therapeutic applications. Biomedicine & Pharmacotherapy 2023; 158: 114131 doi: 10.1016/j.biopha.2022.114131
|
| 14 |
Pedro S. Couto, Nada Al-Arawe, Igor S. Filgueiras, Dennyson L. M. Fonseca, Irene Hinterseher, Rusan A. Catar, Raghavan Chinnadurai, Alexey Bersenev, Otávio Cabral-Marques, Guido Moll, Frances Verter. Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1200180
|
| 15 |
Shengnan Yang, Peipei Liu, Yale Jiang, Zai Wang, Huaping Dai, Chen Wang. Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.639657
|
| 16 |
Wenming Lu, Longxiang Yan, Xingkun Tang, Xuesong Wang, Jing Du, Zhengwei Zou, Lincai Li, Junsong Ye, Lin Zhou. Efficacy and safety of mesenchymal stem cells therapy in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05358-6
|
| 17 |
Mona Saheli, Kayvan Khoramipour, Massoud Vosough, Abbas Piryaei, Masoud Rahmati, Katsuhiko Suzuki. Athletes’ Mesenchymal Stem Cells Could Be the Best Choice for Cell Therapy in Omicron-Infected Patients. Cells 2022; 11(12): 1926 doi: 10.3390/cells11121926
|